Free Republic 2nd Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $23,106
28%  
Woo hoo!! And we're now over 28%!! Thank you all very much!! God bless.

Keyword: plavix

Brevity: Headers | « Text »
  • ACLU Sues To Obtain Documents Showing Catholic Hospitals ‘Harm’ Women

    05/26/2016 9:25:02 AM PDT · by detective · 14 replies
    Breitbart ^ | 26 May 2016 | Dr. Susan Berry
    Truncated titled. Full title:ACLU Sues To Obtain Documents Showing Catholic Hospitals ‘Harm’ Women By Refusing To Perform Abortions A senior staff attorney at the ACLU’s Reproductive Freedom Project says the civil rights organization is filing a lawsuit in the hope of obtaining documents that show Catholic hospitals are “harming” women by taking taxpayer dollars for public services yet upholding their belief in the dignity of every human life.
  • FDA Announces New Boxed Warning on Plavix - Alerts patients, health care professionals to...

    03/12/2010 4:50:36 PM PST · by neverdem · 5 replies · 653+ views
    fda.gov ^ | March 12, 2010 | NA
    FDA NEWS RELEASE For Immediate Release: March 12, 2010 Media Inquiries: Sandy Walsh, 301-796-4669, sandy.walsh@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA FDA Announces New Boxed Warning on Plavix Alerts patients, health care professionals to potential for reduced effectiveness The U.S. Food and Drug Administration today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form. Plavix reduces the risk of heart attack, unstable angina, stroke, and cardiovascular death in patients with cardiovascular disease by making...
  • Gene variant linked to risk of stroke and heart attack for those on Plavix

    08/26/2009 10:17:38 PM PDT · by neverdem · 3 replies · 495+ views
    Contact: Alisa Zapp Machalekalisa.machalek@nih.gov 301-496-7301NIH/National Institute of General Medical Sciences Gene variant linked to risk of stroke and heart attack for those on Plavix NIGMS media availability WHAT: A new study reports that a gene variant carried by about a third of the population plays a major role in this group's response to an anti-clotting medicine, clopidogrel (Plavix). People with the variant produce a defective version of the CYP2C19 enzyme and are less able to activate the drug.One of the world's best-selling medicines, Plavix prevents blood clots in people with heart disease by keeping platelets from sticking together. But about...
  • Early Communication about an Ongoing Safety Review of clopidogrel bisulfate (marketed as Plavix)

    01/26/2009 10:22:43 PM PST · by neverdem · 2 replies · 803+ views
    fda.gov ^ | January 26, 2009 | NA
      This information reflects FDA’s current analysis of available data concerning these drugs. Posting this information does not mean that FDA has concluded there is a cause and effect relationship between the drug products and the emerging safety issue.  Nor does it mean that FDA is advising health care professionals to discontinue prescribing these products. FDA is considering, but has not reached a conclusion about whether this information warrants any regulatory action. FDA intends to update this document when additional information or analyses become availableThe FDA is aware of published reports that clopidogrel (marketed as Plavix) is less effective in some...
  • 'SUPER ASPIRIN' HEART RX

    09/11/2005 1:10:28 AM PDT · by nickcarraway · 9 replies · 1,119+ views
    New York Post ^ | September 5, 2005
    Giving heart-attack patients a dose of "super aspirin" before rather than during a procedure to restore blood flow to the heart could save tens of thousands of lives a year, new research suggests. In a major international study presented yesterday at a meeting here of the European Society of Cardiology, scientists found that giving heart attack victims the drug Plavix when they arrive at the emergency room almost halved the risk of a stroke, a repeated heart attack or death within the first month after angioplasty. Angioplasty, a procedure where doctors thread a needle through the blood vessels and implant...
  • Study: Plavix before angioplasty saves lives

    09/05/2005 1:54:11 PM PDT · by neverdem · 3 replies · 183+ views
    The Seattle Times ^ | September 5, 2005 | Emma Ross
    The Associated Press STOCKHOLM, Sweden — Giving heart-attack patients a dose of "superaspirin" before rather than during a procedure to restore blood flow to the heart could save tens of thousands of lives a year, new research suggests. In a major international study presented yesterday at a meeting of the European Society of Cardiology, scientists found that giving heart-attack victims the drug Plavix when they arrive at the emergency room almost halved the risk of a stroke, a repeated heart attack or death within the first month after angioplasty. Angioplasty, a procedure where doctors thread a needle through the blood...
  • 2nd Drug After Heart Attacks Can Help Patients, 2 Studies Find

    03/10/2005 7:35:30 PM PST · by neverdem · 16 replies · 541+ views
    NY Times ^ | March 10, 2005 | NA
    By THE ASSOCIATED PRESS ORLANDO, Fla., March 9 (AP) - Adding Plavix to other anticlotting drugs typically given to heart attack patients saves lives and prevents second heart attacks, two international studies have found. The strategy, specialists said, is the first big advance in care after heart attacks in more than 10 years, since the efficacy of modern clot-busters was shown. The low-cost and simple treatment of using Plavix will have major effects in community hospitals, where most Americans obtain care, the scientists said. It could also help in poorer countries, where heart surgery and the opening of blocked arteries...
  • Study Raises Questions on Plavix Safety

    01/20/2005 7:09:46 PM PST · by neverdem · 2 replies · 473+ views
    NY Times ^ | January 20, 2005 | GARDINER HARRIS
    Patients taking Plavix, a popular and expensive antistroke drug, experience more than 12 times as many ulcers as patients who take aspirin plus a heartburn pill, a study to be published today in The New England Journal of Medicine found. Up to half of those now taking Plavix do so because their doctors assume that Plavix is safer on the stomach than aspirin, said Dr. Francis K. L. Chan, the study's lead author. Both the American College of Cardiology and the American Heart Association recommend that heart and stroke patients at risk of developing ulcers be given Plavix instead of...